But why are we still waiting on patient 8 & 9 to be dosed when we have 4 sites? Is that hard to find candidates? I think it is time the company owners were a little more informed. After all this IS "The first in man trial" and not the usual drug evaluation. At the very least be informed of delays or timetable modifications. JMT
Add to My Watchlist
What is My Watchlist?